Silicon Chip Writes 64 DNA Sequences in Water, Setting New Enzymatic Benchmark
A semiconductor chip has synthesized 64 unique DNA sequences in water without traditional enzymes, achieving a record-breaking 99.9% accuracy. This breakthrough could slash DNA synthesis costs and turbocharge bioengineering.
For the first time, a silicon chip has directly written 64 distinct DNA sequences in water with near-perfect precision—no biological enzymes required. Researchers at the University of Washington achieved 99.9% accuracy using electrical pulses to control nucleotide assembly, sidestepping the expensive, error-prone enzymes that dominate today’s synthetic biology. This fusion of semiconductor physics and molecular biology could democratize DNA synthesis, making customized genes as accessible as printing a document.
- The chip synthesized 64-mer DNA strands (64 nucleotides long) with just 0.1% errors
- Electrical control replaces expensive enzymes, potentially cutting synthesis costs by 100x
- Next-gen chips could scale to thousands of parallel DNA writes for genome-scale engineering
- Faster, cheaper DNA writing accelerates vaccine development, CRISPR therapies, and molecular computing
What Happened
University of Washington engineers repurposed a standard semiconductor chip to assemble DNA strands nucleotide by nucleotide in water. By applying precise electrical voltages across microscopic electrodes, they guided the step-by-step addition of A, T, C, and G bases with 99.9% accuracy—matching commercial enzymatic methods. The 64 unique sequences averaged 20 nucleotides each, with the longest reaching 64 bases. Crucially, the system avoided the temperature swings and organic solvents that plague conventional DNA synthesis. “We’re essentially running a PCR machine in reverse,” said lead researcher Dr. Kai Thode, referring to how the chip adds bases instead of copying them.
The Bigger Picture
This achievement bridges two transformative technologies: semiconductor manufacturing and synthetic biology. Current DNA synthesis costs ~$0.10 per base, limiting large-scale projects like engineered microbes for carbon capture or bespoke cancer therapies. The UW team estimates their approach could eventually drop that to $0.001 per base. “It’s the difference between handwriting books and inventing the printing press,” said Dr. Lena Chen, a bioengineer at Stanford not involved in the study. “When you remove enzymes from the equation, you remove the biggest bottleneck in scaling synthetic biology.” The research also hints at future hybrid devices where chips both write and read DNA, enabling real-time feedback for bio-computing applications.
What Comes Next
The team aims to scale to 256 parallel DNA writers on a single chip within two years, targeting commercial prototypes by 2026. Major hurdles include extending strand lengths beyond 100 bases and integrating purification steps. Synthetic biology startups are already licensing the technology, with one (HelixWorks) planning benchtop DNA printers for labs by 2027. For consumers, this could mean faster development of mRNA vaccines, affordable gene therapies, and even household DNA printers for educational use—imagine designing custom proteins as easily as coding a website.
Q: How does chip-based DNA synthesis differ from traditional methods?
Instead of using enzymes to link nucleotides, the chip controls DNA assembly with electrical fields—like a molecular 3D printer that builds strands base by base in water.
Q: When will this technology be available to researchers?
Early-access systems could reach synthetic biology labs by 2026, with full commercialization expected by 2028-2030 depending on regulatory approvals.
